# BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation

> **NCT04775095** · — · COMPLETED · sponsor: **Intergroupe Francophone de Cancerologie Thoracique** · enrollment: 163 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- BRAF V600 Mutation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04775095
- **Lead sponsor:** Intergroupe Francophone de Cancerologie Thoracique
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-08
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2023-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04775095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04775095, "BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04775095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*